Esketamine (Spravato): What You Need To Know About Breakthrough The Nasal Spray
There’s tons of excitement in psychiatry after the US Food and Drug Administration advisory committee recently backed esketamine (Spravato), an intranasal form of ketamine for treatment-resistant depression. This is an exciting and hopeful advancement because there hasn’t been a different pharmacologic depression treatment target approved by the agency in decades (Think: Prozac’s arrival in 1986). Like any new drug, the excitement and hope surrounding esketamine (Spravato) needs to be weighed by risks and benefits. Here are a few things you need to know about esketamine (Spravato).
What To Consider When Screening A Ketamine and Esketamine (Spravato) Clinic in Philadelphia
Ketamine Clinics are Popping Up Everywhere - Here's How to Screen Them. Ketamine is one of the most exciting treatments to emerge for mood disorders in decades.
Rapid Relief From Depression: COPE Provides Innovative Options Treatment For St. Louis
Feelings of sadness, anxiety, loss of interest, and hopelessness can accumulate and become crippling.
A Fresh Start and New Hope For Mental Wellness in 2019
Here's how to find happiness in 2019 with COPE Psychiatry.
Common Side Effects of Ketamine and Esketamine (Spravato) Treatment
This article specifically examines side effects that may occur during and after sessions in which ketamine is used to treat depression.